Skip to main content
Maternal fragile sites resulting in maternal mosaic deletions: an additional explanation for false positive cell-free DNA
Updated clinical experience with esoteric aneuploidies on a genome-wide cell-free DNA test
Cause for clinical concern: genome-wide cfDNA for cases screening positive for trisomy 15
Clinical outcomes of genome-wide cell-free DNA (cfDNA) for cases screening positive for trisomy 9
Embracing the challenges of isochromosomes in cell-free DNA prenatal screening
